{"entity":{"type":"insider","cik":"0001557533","url":"/insider/0001557533","json_url":"/insider/0001557533.json","name":"Ajer Jeffrey Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":84,"n_filings":73,"first":"2012-11-14","last":"2024-05-06","span_basis":"filed_date"},"name_variants":[{"name":"Ajer Jeffrey Robert","source":"filing","n_filings":73,"first_seen":"2012-11-14","last_seen":"2024-05-06"}],"transactions":[{"id":2751384,"accession":"0001048477-24-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001048477-24-000073","line_url":"/filing/0001048477-24-000073#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":82.91,"price_display":"82.91","price_state":"stated","total_value":414550.0,"total_display":"414,550.00","total_whole":"414,550","shares_owned_after":66767.0,"shares_owned_after_display":"66,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-06","scope":"insider"},{"id":2526918,"accession":"0001048477-24-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-24-000030","line_url":"/filing/0001048477-24-000030#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":87.07,"price_display":"87.07","price_state":"stated","total_value":348280.0,"total_display":"348,280.00","total_whole":"348,280","shares_owned_after":94047.0,"shares_owned_after_display":"94,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":8405222,"accession":"0001209191-23-050220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050220","line_url":"/filing/0001209191-23-050220#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4359.0,"shares_display":"4,359","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":3007.71,"total_display":"3,007.71","total_whole":"3,008","shares_owned_after":34153.0,"shares_owned_after_display":"34,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":7920280,"accession":"0001048477-23-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001048477-23-000039","line_url":"/filing/0001048477-23-000039#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":60804.0,"shares_owned_after_display":"60,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":8305289,"accession":"0001567619-23-001396","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-23-001396","line_url":"/filing/0001567619-23-001396","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":115.69660204081633,"price_display":"115.70","price_state":"stated","total_value":5669133.5,"total_display":"5,669,133.50","total_whole":"5,669,134","shares_owned_after":45263.0,"shares_owned_after_display":"45,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-27","scope":"insider","n_lines":2},{"id":6790834,"accession":"0001567619-22-019207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-019207","line_url":"/filing/0001567619-22-019207#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":86.12,"price_display":"86.12","price_state":"stated","total_value":258360.0,"total_display":"258,360.00","total_whole":"258,360","shares_owned_after":41088.0,"shares_owned_after_display":"41,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-04","scope":"insider"},{"id":6374462,"accession":"0001209191-22-051304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051304","line_url":"/filing/0001209191-22-051304#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4198.0,"shares_display":"4,198","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":13265.68,"total_display":"13,265.68","total_whole":"13,266","shares_owned_after":38512.0,"shares_owned_after_display":"38,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-26","scope":"insider"},{"id":6829039,"accession":"0001567619-22-015887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-015887","line_url":"/filing/0001567619-22-015887#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":95.62,"price_display":"95.62","price_state":"stated","total_value":286860.0,"total_display":"286,860.00","total_whole":"286,860","shares_owned_after":44088.0,"shares_owned_after_display":"44,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-12","scope":"insider"},{"id":6160657,"accession":"0001567619-22-011966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-011966","line_url":"/filing/0001567619-22-011966#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1308.0,"shares_display":"1,308","price_per_share":78.94,"price_display":"78.94","price_state":"stated","total_value":103253.52,"total_display":"103,253.52","total_whole":"103,254","shares_owned_after":54109.0,"shares_owned_after_display":"54,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider"},{"id":6731614,"accession":"0001567619-22-008576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-008576","line_url":"/filing/0001567619-22-008576#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1180.0,"shares_display":"1,180","price_per_share":82.47,"price_display":"82.47","price_state":"stated","total_value":97314.6,"total_display":"97,314.60","total_whole":"97,315","shares_owned_after":55077.0,"shares_owned_after_display":"55,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-13","filed_date":"2022-04-14","scope":"insider"},{"id":6686825,"accession":"0001567619-22-007808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-007808","line_url":"/filing/0001567619-22-007808#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1381.0,"shares_display":"1,381","price_per_share":79.56,"price_display":"79.56","price_state":"stated","total_value":109872.36,"total_display":"109,872.36","total_whole":"109,872","shares_owned_after":56257.0,"shares_owned_after_display":"56,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-30","filed_date":"2022-03-31","scope":"insider"},{"id":6686822,"accession":"0001567619-22-007808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-007808","line_url":"/filing/0001567619-22-007808#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1618.0,"shares_display":"1,618","price_per_share":79.43,"price_display":"79.43","price_state":"stated","total_value":128517.74,"total_display":"128,517.74","total_whole":"128,518","shares_owned_after":57638.0,"shares_owned_after_display":"57,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"},{"id":6784374,"accession":"0001567619-22-007460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-007460","line_url":"/filing/0001567619-22-007460#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6129.0,"shares_display":"6,129","price_per_share":81.78,"price_display":"81.78","price_state":"stated","total_value":501229.62,"total_display":"501,229.62","total_whole":"501,230","shares_owned_after":59256.0,"shares_owned_after_display":"59,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-23","filed_date":"2022-03-24","scope":"insider"},{"id":6784368,"accession":"0001567619-22-007460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-007460","line_url":"/filing/0001567619-22-007460#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2073.0,"shares_display":"2,073","price_per_share":81.0,"price_display":"81.00","price_state":"stated","total_value":167913.0,"total_display":"167,913.00","total_whole":"167,913","shares_owned_after":65385.0,"shares_owned_after_display":"65,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-22","filed_date":"2022-03-24","scope":"insider"},{"id":5417821,"accession":"0001567619-21-018936","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-018936","line_url":"/filing/0001567619-21-018936#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2739.0,"shares_display":"2,739","price_per_share":73.6,"price_display":"73.60","price_state":"stated","total_value":201590.4,"total_display":"201,590.40","total_whole":"201,590","shares_owned_after":55853.0,"shares_owned_after_display":"55,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":5337039,"accession":"0001209191-21-057702","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057702","line_url":"/filing/0001209191-21-057702#line-2","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3665.0,"shares_display":"3,665","price_per_share":17.78,"price_display":"17.78","price_state":"stated","total_value":65163.7,"total_display":"65,163.70","total_whole":"65,164","shares_owned_after":32510.0,"shares_owned_after_display":"32,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-22","filed_date":"2021-09-24","scope":"insider"},{"id":5298244,"accession":"0001567619-21-007870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-007870","line_url":"/filing/0001567619-21-007870#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1537.0,"shares_display":"1,537","price_per_share":78.81,"price_display":"78.81","price_state":"stated","total_value":121130.97,"total_display":"121,130.97","total_whole":"121,131","shares_owned_after":58250.0,"shares_owned_after_display":"58,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-09","scope":"insider"},{"id":4699219,"accession":"0001567619-21-007368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-007368","line_url":"/filing/0001567619-21-007368#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1652.0,"shares_display":"1,652","price_per_share":74.79,"price_display":"74.79","price_state":"stated","total_value":123553.08,"total_display":"123,553.08","total_whole":"123,553","shares_owned_after":59787.0,"shares_owned_after_display":"59,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":4108038,"accession":"0001567619-21-007083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-007083","line_url":"/filing/0001567619-21-007083#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1181.0,"shares_display":"1,181","price_per_share":76.3,"price_display":"76.30","price_state":"stated","total_value":90110.3,"total_display":"90,110.30","total_whole":"90,110","shares_owned_after":61439.0,"shares_owned_after_display":"61,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-24","filed_date":"2021-03-26","scope":"insider"},{"id":4638662,"accession":"0001567619-21-006721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-006721","line_url":"/filing/0001567619-21-006721#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1308.0,"shares_display":"1,308","price_per_share":77.99,"price_display":"77.99","price_state":"stated","total_value":102010.92,"total_display":"102,010.92","total_whole":"102,011","shares_owned_after":64133.0,"shares_owned_after_display":"64,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-18","filed_date":"2021-03-19","scope":"insider"},{"id":2074624,"accession":"0001567619-20-017890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-017890","line_url":"/filing/0001567619-20-017890#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2121.0,"shares_display":"2,121","price_per_share":79.91,"price_display":"79.91","price_state":"stated","total_value":169489.11,"total_display":"169,489.11","total_whole":"169,489","shares_owned_after":61281.0,"shares_owned_after_display":"61,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-15","scope":"insider"},{"id":2344541,"accession":"0001209191-20-052511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-052511","line_url":"/filing/0001209191-20-052511#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3250.0,"shares_display":"3,250","price_per_share":17.25,"price_display":"17.25","price_state":"stated","total_value":56062.5,"total_display":"56,062.50","total_whole":"56,063","shares_owned_after":25975.0,"shares_owned_after_display":"25,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-09-30","scope":"insider"},{"id":2882821,"accession":"0001209191-20-051388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051388","line_url":"/filing/0001209191-20-051388#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":19.74,"price_display":"19.74","price_state":"stated","total_value":44415.0,"total_display":"44,415.00","total_whole":"44,415","shares_owned_after":20125.0,"shares_owned_after_display":"20,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-21","filed_date":"2020-09-21","scope":"insider"},{"id":2618985,"accession":"0001567619-20-012520","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-012520","line_url":"/filing/0001567619-20-012520#line-3","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":124.0,"price_display":"124.00","price_state":"stated","total_value":1860000.0,"total_display":"1,860,000.00","total_whole":"1,860,000","shares_owned_after":63402.0,"shares_owned_after_display":"63,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":3272249,"accession":"0001567619-20-007786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-007786","line_url":"/filing/0001567619-20-007786#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2407.0,"shares_display":"2,407","price_per_share":79.98,"price_display":"79.98","price_state":"stated","total_value":192511.86,"total_display":"192,511.86","total_whole":"192,512","shares_owned_after":63064.0,"shares_owned_after_display":"63,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-09","scope":"insider"},{"id":3069600,"accession":"0001567619-20-007469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-007469","line_url":"/filing/0001567619-20-007469#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1537.0,"shares_display":"1,537","price_per_share":82.0,"price_display":"82.00","price_state":"stated","total_value":126034.0,"total_display":"126,034.00","total_whole":"126,034","shares_owned_after":65471.0,"shares_owned_after_display":"65,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-01","filed_date":"2020-04-02","scope":"insider"},{"id":2672571,"accession":"0001567619-20-007062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-007062","line_url":"/filing/0001567619-20-007062#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1618.0,"shares_display":"1,618","price_per_share":78.47,"price_display":"78.47","price_state":"stated","total_value":126964.46,"total_display":"126,964.46","total_whole":"126,964","shares_owned_after":67008.0,"shares_owned_after_display":"67,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-26","scope":"insider"},{"id":2672566,"accession":"0001567619-20-007062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-007062","line_url":"/filing/0001567619-20-007062#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2041.0,"shares_display":"2,041","price_per_share":74.36,"price_display":"74.36","price_state":"stated","total_value":151768.76,"total_display":"151,768.76","total_whole":"151,769","shares_owned_after":68626.0,"shares_owned_after_display":"68,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-26","scope":"insider"},{"id":8419159,"accession":"0001209191-19-051407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-051407","line_url":"/filing/0001209191-19-051407#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2375.0,"shares_display":"2,375","price_per_share":18.06,"price_display":"18.06","price_state":"stated","total_value":42892.5,"total_display":"42,892.50","total_whole":"42,893","shares_owned_after":22375.0,"shares_owned_after_display":"22,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-30","filed_date":"2019-10-01","scope":"insider"},{"id":8759788,"accession":"0001209191-19-050587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050587","line_url":"/filing/0001209191-19-050587#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":20.24,"price_display":"20.24","price_state":"stated","total_value":45540.0,"total_display":"45,540.00","total_whole":"45,540","shares_owned_after":18250.0,"shares_owned_after_display":"18,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":7791199,"accession":"0001567619-19-007734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-007734","line_url":"/filing/0001567619-19-007734#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3656.0,"shares_display":"3,656","price_per_share":89.1753,"price_display":"89.18","price_state":"stated","total_value":326024.8968,"total_display":"326,024.90","total_whole":"326,025","shares_owned_after":47475.0,"shares_owned_after_display":"47,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-26","filed_date":"2019-03-27","scope":"insider"},{"id":8610120,"accession":"0001567619-19-007573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-007573","line_url":"/filing/0001567619-19-007573","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4519.0,"shares_display":"4,519","price_per_share":89.98317072361142,"price_display":"89.98","price_state":"stated","total_value":406633.9485,"total_display":"406,633.95","total_whole":"406,634","shares_owned_after":56659.0,"shares_owned_after_display":"56,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-21","filed_date":"2019-03-25","scope":"insider","n_lines":2},{"id":8610112,"accession":"0001567619-19-007383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-007383","line_url":"/filing/0001567619-19-007383#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3728.0,"shares_display":"3,728","price_per_share":93.07,"price_display":"93.07","price_state":"stated","total_value":346964.96,"total_display":"346,964.96","total_whole":"346,965","shares_owned_after":59248.0,"shares_owned_after_display":"59,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider"},{"id":6756093,"accession":"0001567619-18-006564","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-18-006564","line_url":"/filing/0001567619-18-006564","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":92.15098243333334,"price_display":"92.15","price_state":"stated","total_value":829358.8419,"total_display":"829,358.84","total_whole":"829,359","shares_owned_after":52934.0,"shares_owned_after_display":"52,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-14","filed_date":"2018-11-16","scope":"insider","n_lines":4},{"id":6449459,"accession":"0001567619-18-003780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-003780","line_url":"/filing/0001567619-18-003780#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":98.9848,"price_display":"98.98","price_state":"stated","total_value":98984.8,"total_display":"98,984.80","total_whole":"98,985","shares_owned_after":49135.0,"shares_owned_after_display":"49,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-03","filed_date":"2018-10-05","scope":"insider"},{"id":6707793,"accession":"0001209191-18-051998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-051998","line_url":"/filing/0001209191-18-051998#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6750.0,"shares_display":"6,750","price_per_share":56.76,"price_display":"56.76","price_state":"stated","total_value":383130.0,"total_display":"383,130.00","total_whole":"383,130","shares_owned_after":15750.0,"shares_owned_after_display":"15,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-20","filed_date":"2018-09-21","scope":"insider"},{"id":6390297,"accession":"0001140361-18-028475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-028475","line_url":"/filing/0001140361-18-028475#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1436.0,"shares_display":"1,436","price_per_share":90.31,"price_display":"90.31","price_state":"stated","total_value":129685.16,"total_display":"129,685.16","total_whole":"129,685","shares_owned_after":50135.0,"shares_owned_after_display":"50,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-13","scope":"insider"},{"id":6066203,"accession":"0001140361-18-022619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-022619","line_url":"/filing/0001140361-18-022619#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":309.0,"shares_display":"309","price_per_share":85.96,"price_display":"85.96","price_state":"stated","total_value":26561.64,"total_display":"26,561.64","total_whole":"26,562","shares_owned_after":52914.0,"shares_owned_after_display":"52,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-09","scope":"insider"},{"id":6134688,"accession":"0001140361-18-016894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-016894","line_url":"/filing/0001140361-18-016894#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2119.0,"shares_display":"2,119","price_per_share":80.12,"price_display":"80.12","price_state":"stated","total_value":169774.28,"total_display":"169,774.28","total_whole":"169,774","shares_owned_after":52914.0,"shares_owned_after_display":"52,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-03","scope":"insider"},{"id":6612880,"accession":"0001140361-18-016271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-016271","line_url":"/filing/0001140361-18-016271#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1537.0,"shares_display":"1,537","price_per_share":79.69,"price_display":"79.69","price_state":"stated","total_value":122483.53,"total_display":"122,483.53","total_whole":"122,484","shares_owned_after":55033.0,"shares_owned_after_display":"55,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-29","filed_date":"2018-03-30","scope":"insider"},{"id":6461546,"accession":"0001140361-18-014807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-014807","line_url":"/filing/0001140361-18-014807#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4368.0,"shares_display":"4,368","price_per_share":83.9,"price_display":"83.90","price_state":"stated","total_value":366475.2,"total_display":"366,475.20","total_whole":"366,475","shares_owned_after":60153.0,"shares_owned_after_display":"60,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-21","filed_date":"2018-03-23","scope":"insider"},{"id":6461491,"accession":"0001140361-18-013341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-013341","line_url":"/filing/0001140361-18-013341#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2972.0,"shares_display":"2,972","price_per_share":82.39,"price_display":"82.39","price_state":"stated","total_value":244863.08,"total_display":"244,863.08","total_whole":"244,863","shares_owned_after":55332.0,"shares_owned_after_display":"55,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-09","filed_date":"2018-03-13","scope":"insider"},{"id":4090082,"accession":"0001140361-17-036526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-036526","line_url":"/filing/0001140361-17-036526","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3521.0,"shares_display":"3,521","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":334495.0,"total_display":"334,495.00","total_whole":"334,495","shares_owned_after":47944.0,"shares_owned_after_display":"47,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-22","filed_date":"2017-09-26","scope":"insider","n_lines":2},{"id":4588971,"accession":"0001140361-17-024611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-024611","line_url":"/filing/0001140361-17-024611#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001557533","owner_name":"Ajer Jeffrey Robert","owner_display_name":"Ajer Jeffrey Robert","owner_url":"/insider/0001557533","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1004.0,"shares_display":"1,004","price_per_share":89.61,"price_display":"89.61","price_state":"stated","total_value":89968.44,"total_display":"89,968.44","total_whole":"89,968","shares_owned_after":47944.0,"shares_owned_after_display":"47,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-07","filed_date":"2017-06-09","scope":"insider"}],"collapsed":true,"next_cursor":"2017-06-07|4588971","ledger_fault":false,"count":{"value":84,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":84,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":84},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001048477","name":"BIOMARIN PHARMACEUTICAL INC","url":"/issuer/0001048477","role":"Officer (EVP, Chief Commercial Officer)","n_filings":65,"first_seen":"2012-11-14","last_seen":"2024-05-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Director","n_filings":8,"first_seen":"2018-09-21","last_seen":"2023-09-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001557533","retrieved_at":"2026-08-23T05:25:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}